Experience

Davis Polk advised the underwriters on an SEC-registered offering on Schedule B by Oesterreichische Kontrollbank Aktiengesellschaft of its $1.5 billion 1.625% guaranteed global notes…

Davis Polk advised the joint bookrunners in connection with an SEC-registered offering of $1.5 billion aggregate principal amount of 5.750% perpetual additional tier 1 contingent…

Davis Polk advised the underwriters in connection with an SEC-registered offering of $1 billion aggregate principal amount of 2.789% notes due 2024, $1 billion aggregate principal amount of…

Davis Polk advised Banco Bilbao Vizcaya Argentaria, S.A. on its SEC-registered offering of $1 billion liquidation preference of series 9 non-step-up non-cumulative contingent convertible…

Davis Polk advised Ocado Group plc in connection with its successful solicitation of consents from holders of its 4.00% senior secured notes due 2024 (“2024 Notes”) relating to the…

Davis Polk advised Oryzon Genomics, S.A. on its €20 million private placement of its ordinary shares pursuant to a capital increase. The offering consisted of a private placement to…

Davis Polk advised the initial purchasers in connection with a Rule 144A/Regulation S offering by Pampa Energía S.A. of its 9.125% notes due 2029. Pampa Energía S.A. is the largest…

Davis Polk advised Banco Santander, S.A. in connection with its SEC-registered offering of $1.5 billion aggregate principal amount of 2.706% senior preferred fixed-rate notes due 2024 and …

Davis Polk advised Notre Dame Intermédica Participações S.A. in connection with the equity offering by Bain Capital, the controlling shareholder of Notre Dame Intermédica, of 60,000,000…

Davis Polk advised the initial purchasers in connection with a Rule 144A and Regulation S offering by YY Inc. (NASDAQ: YY) of $425 million aggregate principal amount of 0.750% convertible…